Turn off MathJax
Article Contents
Anmin WANG, Zhongfa LIU, Chunhui YANG, Guangsi ZOU, Chengmin SHI, Yujian ZENG. Concordance and Correlation Analysis of Mismatch Repair and Microsatellite Status in 412 Cases of Colorectal Cancer in Yunnan Province[J]. Journal of Kunming Medical University.
Citation: Anmin WANG, Zhongfa LIU, Chunhui YANG, Guangsi ZOU, Chengmin SHI, Yujian ZENG. Concordance and Correlation Analysis of Mismatch Repair and Microsatellite Status in 412 Cases of Colorectal Cancer in Yunnan Province[J]. Journal of Kunming Medical University.

Concordance and Correlation Analysis of Mismatch Repair and Microsatellite Status in 412 Cases of Colorectal Cancer in Yunnan Province

  • Available Online: 2025-11-27
  •   Objective   To investigate the concordance between mismatch repair (MMR) protein and microsatellite instability (MSI) detection in colorectal cancer (CRC) in Yunnan Province, the similarity of their biological characteristics, and to preliminarily screen independent factors that may lead to discordance between the two detection methods.   Methods   A retrospective collection of medical records from 412 native Yunnan CRC patients who visited the First Affiliated Hospital of Kunming Medical University between January 2021 and December 2024 was conducted. Kappa analysis was employed to assess the concordance between MMR and MSI testing, with percentags representing the matching degree between MMR and MSI status. Chi-square test was used for univariate analysis, Bonferroni correction for multiple comparisons, and logistic regression models for multivariate analysis to further screen independent factors associated with discordance between these two detection methods.   Results   (1) Consistency: Among 412 colorectal cancer patients in Yunnan Province, the incidence of deficient MMR (dMMR) and microsatellite instability-high (MSI-H) were 12.1% and 8.5%, respectively. Using MSI testing as the gold standard, the sensitivity and specificity of MMR testing were 82.9% and 94.4%, respectively, with positive and negative predictive values of 58.0% and 98.3%, respectively. The overall concordance rate between the two tests was 93.5%. Kappa analysis demonstrated high concordance between the two assays across the general population, Han Chinese patients, and ethnic minority patients (general population: Kappa=0.647 > 0.6, P < 0.001; Han Chinese patients: Kappa=0.621 > 0.6, P < 0.001; ethnic minority patients: Kappa=0.808 > 0.8, P < 0.001). (2) MMR protein deficiency patterns: Among 50 dMMR patients, the most prevalent deficiency type was combined MLH1-PMS2 deletion (42.0%), and MSI-H accounted for 58.0% in dMMR patients, of which MSH2-MSH6 combined deficiency showed the highest proportion of MSI-H (85.7%). (3) Biological characteristic similarities: History of polyposis, tumour location, differentiation degree, and M stage were all independently associated with MSI and MMR status. Additionally, MSI status was independently associated with age, family history of cancer, and tumour size (P < 0.05). (4) Independent factors associated with MMR-MSI test concordance: History of polyposis and tumour location were independently associated with concordance between the two tests; while tumour location and differentiation degree were independently associated with concordance of MSI detection in dMMR (P < 0.05).   Conclusion   In Yunnan Province, MMR and MSI testing for colorectal cancer (CRC) demonstrate high concordance and biological characteristic similarity. MSI-H CRC is predominantly found in patients with age <50 years, family history of tumors or history of polyps, tumor diameter ≥5 cm, right-sided colon cancer, poorly differentiated carcinoma, and without distant metastases. Clinically, attention should be paid to further verification of discordant results between MMR and MSI detection: overall, CRC with history of polyps and non-rectal location is more prone to discordance between the two detection methods; while in dMMR type CRC, patients with moderately to well-differentiated carcinoma and left-sided colon cancer are more prone to discordance between the two detection methods.
  • loading
  • [1]
    Bray F, Laversanne M, Sung H, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J]. CA A Cancer J Clin, 2024, 74(3): 229-263.
    [2]
    Müller M F, Ibrahim A E K, Arends M J. Molecular pathological classification of colorectal cancer[J]. Virchows Arch, 2016, 469(2): 125-134. doi: 10.1007/s00428-016-1956-3
    [3]
    De' Angelis GL, Bottarelli L, Azzoni C, et al. Microsatellite instability in colorectal cancer[J]. Acta Biomed. 2018 Dec 17; 89(9-S): 97-101.
    [4]
    Kanth P, Grimmett J, Champine M, et al. Hereditary colorectal polyposis and cancer syndromes: A primer on diagnosis and management[J]. Am J Gastroenterol, 2017, 112(10): 1509-1525. doi: 10.1038/ajg.2017.212
    [5]
    Copija A, Waniczek D, Witkoś A, et al. Clinical significance and prognostic relevance of microsatellite instability in sporadic colorectal cancer patients[J]. Int J Mol Sci, 2017, 18(1): 107. doi: 10.3390/ijms18010107
    [6]
    Nakaji Y, Oki E, Nakanishi R, et al. Prognostic value of BRAF V600E mutation and microsatellite instability in Japanese patients with sporadic colorectal cancer[J]. J Cancer Res Clin Oncol, 2017, 143(1): 151-160. doi: 10.1007/s00432-016-2275-4
    [7]
    Kubecek O, Trojanova P, Molnarova V, et al. Microsatellite instability as a predictive factor for immunotherapy in malignant melanoma[J]. Med Hypotheses, 2016, 93: 74-76. doi: 10.1016/j.mehy.2016.05.023
    [8]
    Cohen R, Rousseau B, Vidal J, et al. Immune checkpoint inhibition in colorectal cancer: Microsatellite instability and beyond[J]. Target Oncol, 2020, 15(1): 11-24. doi: 10.1007/s11523-019-00690-0
    [9]
    Westdorp H, Fennemann F L, Weren R D A, et al. Opportunities for immunotherapy in microsatellite instable colorectal cancer[J]. Cancer Immunol Immunother, 2016, 65(10): 1249-1259. doi: 10.1007/s00262-016-1832-7
    [10]
    Overman M J, Lonardi S, Wong K Y M, et al. Durable clinical benefit with nivolumab plus ipilimumab in DNA mismatch repair-deficient/microsatellite instability-high metastatic colorectal cancer[J]. J Clin Oncol, 2018, 36(8): 773-779. doi: 10.1200/JCO.2017.76.9901
    [11]
    Xiao J, Li W, Huang Y, et al. A next-generation sequencing-based strategy combining microsatellite instability and tumor mutation burden for comprehensive molecular diagnosis of advanced colorectal cancer[J]. BMC Cancer, 2021, 21(1): 282. doi: 10.1186/s12885-021-07942-1
    [12]
    国家卫生健康委员会医政司, 中华医学会肿瘤学分会. 国家卫生健康委员会中国结直肠癌诊疗规范(2023年版)[J]. 中华胃肠外科杂志, 2023, 26(6): 505-528.
    [13]
    Wankhede D, Yuan T, Kloor M, et al. Clinical significance of combined tumour-infiltrating lymphocytes and microsatellite instability status in colorectal cancer: A systematic review and network meta-analysis[J]. Lancet Gastroenterol Hepatol, 2024, 9(7): 609-619. doi: 10.1016/S2468-1253(24)00091-8
    [14]
    Amin M B, Edge S B, Greene F L, et al. AJCC cancer staging manual[M]. 8th ed. Chicago: Springer, 2017.
    [15]
    Favier A, Varinot J, Uzan C, et al. The role of immunohistochemistry markers in endometrial cancer with mismatch repair deficiency: A systematic review[J]. Cancers, 2022, 14(15): 3783. doi: 10.3390/cancers14153783
    [16]
    Leclerc J, Vermaut C, Buisine M P. Diagnosis of Lynch syndrome and strategies to distinguish lynch-related tumors from sporadic MSI/dMMR tumors[J]. Cancers, 2021, 13(3): 467. doi: 10.3390/cancers13030467
    [17]
    Wong M C S, Huang J, Lok V, et al. Differences in incidence and mortality trends of colorectal cancer worldwide based on sex, age, and anatomic location[J]. Clin Gastroenterol Hepatol, 2021, 19(5): 955-966. e61.
    [18]
    Sougklakos I, Athanasiadis E, Boukovinas I, et al. Treatment pathways and associated costs of metastatic colorectal cancer in Greece[J]. Cost Eff Resour Alloc, 2022, 20(1): 7. doi: 10.1186/s12962-022-00339-2
    [19]
    Ashktorab H, Ahuja S, Kannan L, et al. A meta-analysis of MSI frequency and race in colorectal cancer[J]. Oncotarget, 2016, 7(23): 34546-34557. doi: 10.18632/oncotarget.8945
    [20]
    Wong M C, Ding H, Wang J, et al. Prevalence and risk factors of colorectal cancer in Asia[J]. Intest Res, 2019, 17(3): 317-329. doi: 10.5217/ir.2019.00021
    [21]
    Akagi K, Oki E, Taniguchi H, et al. Real-world data on microsatellite instability status in various unresectable or metastatic solid tumors[J]. Cancer Sci, 2021, 112(3): 1105-1113. doi: 10.1111/cas.14798
    [22]
    Zhang C, Ding H, Sun S, et al. Incidence and detection of high microsatellite instability in colorectal cancer in a Chinese population: A meta-analysis[J]. J Gastrointest Oncol, 2020, 11(6): 1155-1163. doi: 10.21037/jgo-20-487
    [23]
    郭银金, 赵泽元, 王晓雄, 等. 云南地区结直肠癌患者微卫星不稳定状态与临床病理特征的关系[J]. 热带医学杂志, 2024, 24(11): 1570-1574+1642.
    [24]
    Zaanan A, Meunier K, Sangar F, et al. Microsatellite instability in colorectal cancer: From molecular oncogenic mechanisms to clinical implications[J]. Cell Oncol, 2011, 34(3): 155-176. doi: 10.1007/s13402-011-0024-x
    [25]
    Hall G, Clarkson A, Shi A, et al. Immunohistochemistry for PMS2 and MSH6 alone can replace a four antibody panel for mismatch repair deficiency screening in colorectal adenocarcinoma[J]. Pathology, 2010, 42(5): 409-413. doi: 10.3109/00313025.2010.493871
    [26]
    Yearsley M, Hampel H, Lehman A, et al. Histologic features distinguish microsatellite-high from microsatellite-low and microsatellite-stable colorectal carcinomas, but do not differentiate germline mutations from methylation of the MLH1 promoter[J]. Hum Pathol, 2006, 37(7): 831-838. doi: 10.1016/j.humpath.2006.02.009
    [27]
    矣金华. 结直肠癌CpG岛甲基化表型(CIMP)与错配修复基因表达缺失相关性研究[D]. 昆明: 昆明医科大学, 2016.
    [28]
    Li G M. Mechanisms and functions of DNA mismatch repair[J]. Cell Res, 2008, 18(1): 85-98. doi: 10.1038/cr.2007.115
    [29]
    Mei W J, Mi M, Qian J, et al. Clinicopathological characteristics of high microsatellite instability/mismatch repair-deficient colorectal cancer: A narrative review[J]. Front Immunol, 2022, 13: 1019582. doi: 10.3389/fimmu.2022.1019582
    [30]
    Sameer A S, Nissar S, Fatima K. Mismatch repair pathway: Molecules, functions, and role in colorectal carcinogenesis[J]. Eur J Cancer Prev, 2014, 23(4): 246-257. doi: 10.1097/CEJ.0000000000000019
    [31]
    Lizardo D Y, Kuang C, Hao S, et al. Immunotherapy efficacy on mismatch repair-deficient colorectal cancer: From bench to bedside[J]. Biochim Biophys Acta Rev Cancer, 2020, 1874(2): 188447. doi: 10.1016/j.bbcan.2020.188447
    [32]
    赵喜连, 郗彦凤, 白文启, 等. 错配修复蛋白和p53蛋白表达与结直肠癌的临床病理关系及其相关性[J]. 临床与实验病理学杂志, 2016, 32(4): 370-374+379. doi: 10.13315/j.cnki.cjcep.2016.04.003
    [33]
    王安民, 银明, 王紫薇, 等. 青年与中老年结直肠癌临床病理特征及预后对比的meta分析[J]. 重庆医学, 2025, 54(2): 489-495.
    [34]
    Kawakami H, Zaanan A, Sinicrope F A. Microsatellite instability testing and its role in the management of colorectal cancer[J]. Curr Treat Options Oncol, 2015, 16(7): 30. doi: 10.1007/s11864-015-0348-2
    [35]
    Evrard C, Tachon G, Randrian V, et al. Microsatellite instability: Diagnosis, heterogeneity, discordance, and clinical impact in colorectal cancer[J]. Cancers, 2019, 11(10): 1567. doi: 10.3390/cancers11101567
    [36]
    Cheah P L, Li J, Looi L M, et al. Screening for microsatellite instability in colorectal carcinoma: Practical utility of immunohistochemistry and PCR with fragment analysis in a diagnostic histopathology setting[J]. Malays J Pathol, 2019, 41(2): 91-100.
    [37]
    Chen J, Yan Q, Sun J, et al. Microsatellite status detection of colorectal cancer: Evaluation of inconsistency between PCR and IHC[J]. J Cancer, 2023, 14(7): 1132-1140. doi: 10.7150/jca.81675
    [38]
    Joost P, Veurink N, Holck S, et al. Heterogenous mismatch-repair status in colorectal cancer[J]. Diagn Pathol, 2014, 9: 126. doi: 10.1186/1746-1596-9-126
    [39]
    Chen W, Frankel W L. A practical guide to biomarkers for the evaluation of colorectal cancer[J]. Mod Pathol, 2019, 32(Suppl 1): 1-15.
    [40]
    McCarthy A J, Capo-Chichi J M, Spence T, et al. Heterogenous loss of mismatch repair (MMR) protein expression: A challenge for immunohistochemical interpretation and microsatellite instability (MSI) evaluation[J]. J Pathol Clin Res, 2019, 5(2): 115-129. doi: 10.1002/cjp2.120
    [41]
    朱惠, 蔡继东, 李溟涵, 等. 结肠直肠癌错配修复蛋白表达与微卫星稳定性的一致性分析[J]. 外科理论与实践, 2024, 29(2): 148-155. doi: 10.16139/j.1007-9610.2024.02.10
  • Relative Articles

    [1] Yueting YAO, Shuai LI, Yang CAO, Mu LIN, Zhengguang LUO, Xiaobo CHEN, Qianli MA. Correlation between Epidermal Growth Factor Gene Polymorphisms and Non-small Cell Lung Cancer. Journal of Kunming Medical University,  doi: 10.12259/j.issn.2095-610X.S20250910
    [2] Rongmei LIN, Bangyan LIU, Yangjun CHEN, Yan YANG, Yuan JIN, Yongrui YANG, Nihong LU. Correlation of Multiple Clinical Indicators with Benign and Malignant Pulmonary Nodules. Journal of Kunming Medical University,  doi: 10.12259/j.issn.2095-610X.S20250712
    [3] Weili LI, Danhua RU, Dan XIE, Jing ZHANG, Ya CHANG, Zhaoxin YANG. Correlation between Serum IL-10,CTL and EB Virus Associated Infectious Mononucleosis Complicated with Liver Damage in Children. Journal of Kunming Medical University,
    [4] Zhixin NIU, Lihua TANG, Lei SHI, Chao HONG, Yufeng YAO, Zhiling YAN. Correlation of MAPK1 and NRAS Gene Polymorphisms with Cervical Intraepithelial Neoplasia in Yunnan Han Population. Journal of Kunming Medical University,  doi: 10.12259/j.issn.2095-610X.S20240502
    [5] Yan DONG, Wenwen LI, Wenlong CUI, Jie LIU, Weihong BI. Correlation Analysis of Chronic Diseases and Physical Labor Intensity among the Rural Elderly in Two Counties of Yunnan Province. Journal of Kunming Medical University,  doi: 10.12259/j.issn.2095-610X.S20230303
    [6] Yan LIANG, Lei WANG, Ming LEI, Benchao CHEN, Ping SUN, Shuai LI, Li LIU, Qianrong WANG, Manlin LIAO, Qianli MA. Correlation between KRAS Gene Polymorphism and Non-small Cell Lung Cancer in Yunnan Han Population. Journal of Kunming Medical University,  doi: 10.12259/j.issn.2095-610X.S20230210
    [7] Jianheng AO, Lei MIAO, Huiying WANG, Tianyun ZHANG, Tao WANG, Yonghang TANG, Liping HU, Shengjie NIE. Correlation between DNA Detection Rate and Sweat Pore Density of Palm Touch Biological Samples. Journal of Kunming Medical University,  doi: 10.12259/j.issn.2095-610X.S20230601
    [8] Xiaohua LU, Hongxin YUAN. The Analysis of the Correlation between BTLA,CTLA-4 Gene Polymorphisms and the Efficacy and Prognosis of TACE Combined Targeted Therapy for Liver Cancer. Journal of Kunming Medical University,  doi: 10.12259/j.issn.2095-610X.S20230927
    [9] Rong LIU, Yang SUN, Fameng LUO, Dezhi TAO, Haiyan ZHANG. Correlation between the Acceptance of Illness and Quality of Life in Patients with Inflammatory Bowel Disease. Journal of Kunming Medical University,  doi: 10.12259/j.issn.2095-610X.S20220507
    [10] Yanfen MA, Jian HU, Depei CAI, Yongfeng QIAO, Xiaoqin WANG. Correlation between Serum Gamma-glutamyl Transferase Level and Blood Lipid Indexes in 3137 Checkup Population. Journal of Kunming Medical University,  doi: 10.12259/j.issn.2095-610X.S20221001
    [11] Xin WU, Yun LI, Pin-fei ZOU, Mei-ling LI, Yong-bin PU. The Detection Rate of Musculoskeletal Ultrasound in Patients with Rheumatic Knee Arthritis and Its Correlation with Knee Function. Journal of Kunming Medical University,  doi: 10.12259/j.issn.2095-610X.S20210814
    [12] Juan-juan WANG, Yu-qing CHEN, Qian DENG, Jian GAO. The Correlation between Myocardial Enzymes and the Severity of Ketoacidosis in Children with Type 1 Diabetes. Journal of Kunming Medical University,  doi: 10.12259/j.issn.2095-610X.S20210129
    [13] Ying HUANG, Xiang LI, Shan JIANG, Bing LIU, Yan-ling ZHANG, Yang LI, Hua HE, Yan WU, Yun LUO, Jun XU. Correlation Analysis of Chest Imaging and Laboratory Indicators in Patients with 2019-nCoV Infection. Journal of Kunming Medical University,  doi: 10.12259/j.issn.2095-610X.S20211232
    [14] Yang Jing Yu , Li Wen Liang . . Journal of Kunming Medical University,
    [15] Zhang Hong . . Journal of Kunming Medical University,
    [16] Mei Xue . . Journal of Kunming Medical University,
    [17] Zheng Hong Mei . . Journal of Kunming Medical University,
    [18] Zhao Jin You . . Journal of Kunming Medical University,
    [19] Zhong Lin . . Journal of Kunming Medical University,
    [20] Yang Yi Ming . Clinical Experiences in Diagnosis and Treatment of Intestinal Obstruction of 48 Patients with Colorectal Cancer. Journal of Kunming Medical University,
  • 加载中

Catalog

    通讯作者: 陈斌, bchen63@163.com
    • 1. 

      沈阳化工大学材料科学与工程学院 沈阳 110142

    1. 本站搜索
    2. 百度学术搜索
    3. 万方数据库搜索
    4. CNKI搜索

    Tables(6)

    Article Metrics

    Article views (44) PDF downloads(4) Cited by()
    Proportional views
    Related

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return